Prevalence and Burden of Bronchiectasis in Tuberculous Patients
1 other identifier
observational
50
1 country
1
Brief Summary
Bronchiectasis was described in the early 19th century by Laennec. Bronchiectasis is a chronic condition characterized by permanent and irreversible dilatation of the bronchial airways and impairment of mucociliary transport mechanism due to repeated infection and inflammation leading to colonization of organism and pooling of the mucus in the bronchial tree
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 28, 2019
CompletedFirst Posted
Study publicly available on registry
September 11, 2019
CompletedStudy Start
First participant enrolled
September 26, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2020
CompletedFebruary 17, 2023
September 1, 2019
3 months
May 28, 2019
February 15, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
To study prevalence of bronchiectasis in TB patients by case per year.
How many patients of TB will be diagnosed as abronchiectasis
One year
Secondary Outcomes (1)
To evaluate the burden of bronchiectasis in TB patients
one year
Interventions
Sputum sample for T.B will be done using gene expert device and chest xray and high resolution ct to evaluate bronchectasis
Eligibility Criteria
Any tuberculosis patients admited to assuit university hospital and assuit chest hospital
You may qualify if:
- patients were diagnosed to have tuberculosis by sputum culture and gene x pert.
- patients were diagnosed to have bronchiectasis after lab and radiological examination as well as clinical score.
- patients diagnosed as bronchiectasis after history of tuberculosis or anti Tuberculosis treatment with positive or negative tuberculous culture in the time of research.
You may not qualify if:
- patients presented with other Pulmonary diseases. 2-Chronic liver and renal disease . 3- Lung cancer and tumors. 4- patients were previously diagnosed as bronchiectasis .
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assiut unviresty
Asyut, 71511, Egypt
Biospecimen
Sputum by gene xpert
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 2 Weeks
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- DR.Ahmad Shaddad
Study Record Dates
First Submitted
May 28, 2019
First Posted
September 11, 2019
Study Start
September 26, 2019
Primary Completion
January 1, 2020
Study Completion
April 1, 2020
Last Updated
February 17, 2023
Record last verified: 2019-09